I The pharmacological properties of N-2-hydroxyethyl-N-methyl pyrrolidinium (pyrrolcholine) and its acetate ester, recently shown to be a false transmitter at the cholinergic electromotor synapses in Torpedo marmorata, also those of the corresponding morpholinium compounds (morpholinecholine, acetylmorpholinecholine), have been studied on the guinea-pig ileum, frog heart, frog rectus abdominis muscle, rat blood pressure, rat gastrocnemius muscle and dorsal muscle of the leech. 2 Acetylpyrrolcholine and acetylmorpholinecholine are full cholinoceptor agonists with doseresponse curves parallel to that of acetylcholine. They are, however, less potent. Acetylpyrrolcholine is relatively more potent as a muscarinic drug (molar potency about 30% of that of acetylcholine in the ileum but only 4% on the leech) whereas acetylmorpholinecholine is more strongly nicotinic. The unacetylated compounds are very weak agonists with potencies comparable to that of choline. 3 Pyrrolcholine in high concentration showed a distinct neuromuscular blocking effect in the rat gastrocnemius muscle preparation. It is likely that this is a direct effect and not due to uptake by the presynaptic nerve terminals followed by conversion to a false transmitter since it was not reduced by hemicholinium-3, which is known to block uptake of choline and choline analogues by the presynaptic high affinity choline uptake system.
Introduction
The concept of a 'false transmitter' is well established in the pharmacology of the sympathetic nervous system. Briefly, it is a substance which is taken up into adrenergic nerve terminals, and thence into synaptic vesicles, and on stimulation is released along with noradrenaline. Since many such substances are less active agonists than the natural transmitter, a partial blockade of synaptic transmission may result. The demonstration that only those substances which enter synaptic vesicles are released on stimulation has constituted important evidence for the 'vesicle hypothesis' in the adrenergic system (for review see Smith, 1972) .
In principle, false transmitters should exist in the cholinergic system too, since it is unlikely that the storage mechanism in cholinergic terminals is completely specific for acetylcholine. However, the process by which acetylcholine is taken up into cholinergic synaptic vesicles is more complex and involves at least three steps: the entry of choline into the terminal via a high affinity choline permease (for references see Whittaker & Dowdall, 1975) , the acetylation of choline to acetylcholine, a process known to be cytoplasmic in location (Fonnum, 1967) and the uptake of acetylcholine into the vesicles. The identification of false transmitters in the cholinergic system thus involves experiments with unesterified precursors, analogues of choline which are both taken up and acetylated.
Recent work has shown that the compound N-2-hydroxyethyl-N-methylpyrrolidinium (trivial name: pyrrolcholine) is a false transmitter precursor in the cholinergic electromotor system of Torpedo (Zimmermann & Dowdall, 1975a ,b, 1976 Dowdall, Fox, Wachtler, Whittaker & Zimmermann, 1976) since the acetylated product is taken up into vesicles (as shown by subsequent isolation) and released on stimulation. Evidence for release from mammalian cholinergic endings is also forthcoming (Glick, Crane,  Coflier, Barker & Mittag, 1976) . A knowledge of the pharmacological properties of this compound and its acetate ester is thus of interest. Only a brief study of the acetate has so far appeared (Cho, Jenden & Lamb, 1972) . In the study now to be described another putative false transmitter precursor N-2-hydroxyethyl-N-methyl morpholinium (trivial name: morpholinecholine) and its acetate ester have also been investigated for comparison. 
Methods

Materials
Pyrrolcholine and morpholinecholine were synthesized as iodides according to ; they were acetylated with acetylchloride according to Widlund & Heilbronn (1974) and the acetylation reaction was followed by the hydroxamate method (Hestrin, 1949) . Acetylcholine perchlorate was used as a reference compound.
Pharmacological preparations
The following preparations were used: leech dorsal muscle, frog rectus abdominis muscle, guinea-pig ileum (all as described by Whittaker & Barker, 1972) , perfused frog heart, (Bum, 1952) , rat blood pressure and sciatic nerve-gastrocnemius muscle preparation (Chiou, 1974 (Litchfield & Wilcoxon, 1949) .
The LD50 values of pyrrolcholine and acetylpyrrolcholine were determined in mice (20-25 g) according to Litchfield & Wilcoxon (1949) . The drugs, dissolved in 0.9% w/v NaCl solution (saline), were given intraperitoneally in a volume of0.1 ml.
Results
The results obtained with the various preparations mentioned above are summarized in Table 1 ; in columns 5-6 they are expressed as equipotent molar ratios and the figures are therefore inversely proportional to molar activities. Acetylpyrrolcholine and acetylmorpholinecholine are both full cholinoceptor agonists which reach an intrinsic activity of 1 (100% effect). Their dose-response curves are parallel to that of acetylcholine, and are shifted to the right (Figure 1) , from which one may conclude that their affinity for the postsynaptic receptor is lower than that of acetylcholine. As can be seen from Table 1 , acetylpyrrolcholine is a rather more potent muscarinic stimulant whereas acetylmorpholinecholine has a stronger effect at the nicotinic receptor. By contrast, the unacetylated choline analogues were very weak agonists with potencies comparable to that of choline.
The nicotinic effect of acetylpyrrolcholine and acetylmorpholinecholine is blocked by (+)-tubocurarine to approximately the same extent as acetylcholine. In all cases the dose-response curves are parallel and shifted to the right (Figure 2 ). The muscarinic effect of acetylpyrrolcholine can be blocked competitively by atropine ( Figure 2 ).
As seen in Figure 3a ,b the fall of blood pressure (lower tracings) in the rat is very short-lasting. Doses of acetylpyrrolcholine or acetylmorpholinecholine which halve the blood pressure produce only a very feeble blockade of neuromuscular transmission (upper traces). Only after pretreatment with atropine (0.25 mg/kg) and physostigmine (0.5 mg/kg; Figure 3c ,d) is there a more marked reduction of the muscle contractions. This suggests that both esters are hydrolyzed by cholinesterases at about the same rate as acetylcholine. On the other hand, the precursors pyrrolcholine and morpholinecholine in high concentrations show a distinct neuromuscular blocking effect which is present without any pretreatment (Figure 4a,b) . Morpholinecholine has no influence on the blood pressure whereas pyrrolcholine has a strongly pressor effect. In view of the very rapid response after drug injection it is unlikely that the effects observed are indirect and due to a false transmitter action. More likely what we are seeing is a direct reaction on the postsynaptic receptor. To test this further we repeated the experiments after pretreatment of the rat with hemicholinium-3 (1 mg/kg) to block the presynaptic uptake of the false transmitter precursor. Figure 5 shows that there is no failure of the pyrrolcholine effect on neuromuscular transmission as would be expected in the case of an indirect mechanism.
Preliminary studies of the toxicity of acetylpyrrolcholine and its precursor pyrrolcholine showed an LD50, by intraperitoneal injection (95% confidence limits in parentheses), for acetylpyrrolcholine iodide, 76 mg/kg (65-87 mg/kg) and for pyrrolcholine iodide, 225 mg/kg (210-241 mg/kg). After administration of acetylpyrrolcholine the animals exhibited evidence of cholinoceptor stimulation (lacrimation, salivation and reduction of motility). Tremor was present only in some cases and then only very weakly.
Discussion
In Table 2 the affinity of the two precursors for the synaptosomal high-affinity choline permease (as measured by their ability to inhibit choline uptake at low choline concentration) and their rate of acetylation by choline acetyltransferase are given to show that both compounds interact with the permease and are acetylated: however morpholinecholine is a poor substrate for choline acetyltransferase and a poor inhibitor of choline uptake; it is thus unlikely to compete effectively with choline for uptake and acetylation and its role as a false transmitter precursor has so far not been confirmed. By contrast, pyrrolcholine is a somewhat better substrate for acetylation and is much more readily taken up into the terminals; in the Torpedo ) the acetylated product is known to be taken up into vesicles (by isolation of the vesicles and chromatographic identification of the ester) and to be released, along with acetylcholine, on stimulation, and there is evidence for release from mammalian cholinergic endings also (Glick et al., 1975; Collier et al., 1976) . Since the acetylated product is considerably less potent as a cholinergic agonist than acetylcholine one might have expected pyrrolcholine to exert a synaptic blocking effect indirectly by way of conversion to a false transmitter. Although it did have a considerable blocking effect on the rat neuromuscular junction we were unable to demonstrate that this was other than a direct effect on the muscle cholinoceptors themselves. It remains to be seen whether effects consistent with a false transmitter precursor action would be uncovered at low doses and longer time intervals.
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